Explore peptide research and guides on semaglutide safety.
Semaglutide safety data from SUSTAIN 6, SELECT, SOUL, and STEP trials spanning over 30,000 patients and up to 4 years of follow-up, covering GI, cardiac, cancer, and other risks.